目的探讨阿莫西林克拉维酸钾分散片联合注射用炎琥宁治疗小儿肺炎的疗效。方法选取100例肺炎患儿,随机分为两组,对照组(48例)在常规治疗基础上给予注射用炎琥宁8 mg/kg,加入100 m L 5%葡萄糖注射液静脉滴注,1 d/次;观察组(52例)在对照组治疗基础之上,服用阿莫西林克拉维酸钾片1片/次,2次/d,餐时服用。治疗5~7 d。通过治疗后的疗效,咳嗽、肺部湿啰音消失时间、退热时间、肺功能指标及治疗期间不良反应情况,评价阿莫西林克拉维酸钾分散片联合注射用炎琥宁治疗小儿肺炎的疗效。结果观察组有效率92.3%,对照组有效率75.0%,观察组的治疗有效率高于对照组,差异有统计学意义(P<0.05)。治疗后,观察组患儿咳嗽、肺部湿啰音消失时间明显短于对照组,差异有统计学意义(P<0.05);退热时间与对照组相比,没有显著性差异。治疗前,两组FVC、FEV1和FEV1/FVC相比,差异无统计学意义;治疗后两组FVC、FEV1和FEV1/FVC均明显升高,同组治疗前后比较差异有统计学意义(P<0.05),且观察组上述肺功能指标高于对照组,组间比较差异有统计学意义(P<0.05)。治疗期间,两组不良反应率无统计学差异。结论阿莫西林克拉维酸钾分散片联合注射用炎琥宁治疗小儿肺炎具有较好的治疗效果,能显著改善小儿肺炎症状,在抑制炎症的同时提高患儿肺功能,用药安全,值得临床推广使用。 Objective To investigate the therapeutic effect of amoxicillin and clavulanate potassium dispersible tablets combined with injection of mesylate on infantile pneumonia. Methods 100 children with pneumonia were selected and randomly divided into two groups. The control group (48 cases) was given Yanhuoning 8 mg / kg for injection on the basis of routine treatment. 100 ml of 5% dextrose injection d / time; observation group (52 cases) in the control group based on the treatment, taking amoxicillin potassium clavulanate tablets 1 / times, 2 times / d, meal time. Treatment of 5 ~ 7 d. The effect of amoxicillin and clavulanate dispersible tablet combined with injection of mesylate on children with pneumonia was evaluated by curative effect, cough, disappearance time of lung wet rales, antipyretic time, pulmonary function indexes and adverse reactions during treatment Efficacy. Results The effective rate was 92.3% in the observation group and 75.0% in the control group, and the treatment efficiency in the observation group was higher than that in the control group (P <0.05). After treatment, the observation group cough, lung wet rales disappeared significantly shorter than the control group, the difference was statistically significant (P <0.05); antipyretic time compared with the control group, there was no significant difference. Before treatment, there was no significant difference between the two groups in FVC, FEV1 and FEV1 / FVC. After treatment, the FVC, FEV1 and FEV1 / FVC of the two groups were significantly increased, the difference was statistically significant before and after treatment (P < 0.05). The pulmonary function indexes in the observation group were higher than those in the control group, with significant difference between the two groups (P <0.05). During treatment, there was no significant difference in adverse reactions between the two groups. Conclusion Amoxicillin clavulanate dispersible tablets combined with injection of mesylate for the treatment of children with pneumonia has a good therapeutic effect, can significantly improve the symptoms of children with pneumonia, inhibit the inflammation at the same time improve children’s lung function, medication safety, worthy of clinical promotion use.